Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

300 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19.
Shebley M, Wang S, Ali I, Krishnan P, Tripathi R, Reardon JM, Cafardi J, Rahav G, Caraco Y, Slim J, Al Akhrass F, Yu M, Hu Y, Ferreira RA, Alami NN. Shebley M, et al. Among authors: rahav g. Pharmacol Res Perspect. 2023 Feb;11(1):e01036. doi: 10.1002/prp2.1036. Pharmacol Res Perspect. 2023. PMID: 36537346 Free PMC article. Clinical Trial.
The effect of HIV on COVID-19 vaccine responses.
Levy I, Rahav G. Levy I, et al. Among authors: rahav g. Curr Opin HIV AIDS. 2023 May 1;18(3):135-141. doi: 10.1097/COH.0000000000000790. Epub 2023 Mar 14. Curr Opin HIV AIDS. 2023. PMID: 36943427 Review.
Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial.
Chastre J, François B, Bourgeois M, Komnos A, Ferrer R, Rahav G, De Schryver N, Lepape A, Koksal I, Luyt CE, Sánchez-García M, Torres A, Eggimann P, Koulenti D, Holland TL, Ali O, Shoemaker K, Ren P, Sauser J, Ruzin A, Tabor DE, Akhgar A, Wu Y, Jiang Y, DiGiandomenico A, Colbert S, Vandamme D, Coenjaerts F, Malhotra-Kumar S, Timbermont L, Oliver A, Barraud O, Bellamy T, Bonten M, Goossens H, Reisner C, Esser MT, Jafri HS; COMBACTE-MAGNET EVADE Study Group. Chastre J, et al. Among authors: rahav g. Crit Care. 2022 Nov 15;26(1):355. doi: 10.1186/s13054-022-04204-9. Crit Care. 2022. PMID: 36380312 Free PMC article. Clinical Trial.
Sink-traps are a major source for carbapenemase-producing Enterobacteriaceae transmission.
Regev-Yochay G, Margalit I, Smollan G, Rapaport R, Tal I, Hanage WP, Pinas Zade N, Jaber H, Taylor BP, Che Y, Rahav G, Zimlichman E, Keller N. Regev-Yochay G, et al. Among authors: rahav g. Infect Control Hosp Epidemiol. 2024 Mar;45(3):284-291. doi: 10.1017/ice.2023.270. Epub 2023 Dec 27. Infect Control Hosp Epidemiol. 2024. PMID: 38149351
Group B streptococcus virulence factors associated with different clinical syndromes: Asymptomatic carriage in pregnant women and early-onset disease in the newborn.
Schindler Y, Rahav G, Nissan I, Treygerman O, Prajgrod G, Attia BZ, Raz R, Valenci GZ, Tekes-Manova D, Maor Y. Schindler Y, et al. Among authors: rahav g. Front Microbiol. 2023 Feb 13;14:1093288. doi: 10.3389/fmicb.2023.1093288. eCollection 2023. Front Microbiol. 2023. PMID: 36860481 Free PMC article.
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Maertens JA, Rahav G, Lee DG, Haider S, Ramirez-Sanchez IC, Klimko N, Ponce-de-León A, Han S, Wrishko R, Winchell GA, Grandhi A, Waskin H; study investigators. Maertens JA, et al. Among authors: rahav g. Clin Drug Investig. 2023 Sep;43(9):681-690. doi: 10.1007/s40261-023-01282-7. Epub 2023 Sep 7. Clin Drug Investig. 2023. PMID: 37676612 Free PMC article. Clinical Trial.
300 results